Headache & Pain

Filter Your Results

 

News

 

Once-Daily Lyrica Formulation Wins FDA Approval

Thursday, October 12, 2017—The FDA has approved Lyrica CR (pregabalin, Pfizer) extended-release tablets CV as once-daily therapy for the management of neuropathic pain associated with diabetic periphera…

FDA Approves Intellis Device for Intractable Pain

Wednesday, September 20, 2017—The FDA has approved the Intellis platform (Medtronic) for the management of certain types of chronic intractable pain. The Intellis platform was designed to overcome limitati…

Non-Invasive Neuromodulation Device for Chronic Intractable Pain Cleared by FDA

Tuesday, August 01, 2017—The FDA has cleared the Stimpod NMS460 (Xavant Technology), a non-invasive neuromodulation device for the symptomatic relief and management of chronic intractable pain. When a…

AHS 2017: Amgen’s CGRP Inhibitor Reduces Migraine Days

Tuesday, June 13, 2017—New Phase 2 data show that Amgen’s investigational investigational CGRP inhibitor erenumab is effective at preventing migraine in patients experiencing 15 or more migrai…

AHS 2017 Meeting: Non-Invasive Medical Devices Show Promise for Severe Headaches

Thursday, June 08, 2017—Results from studies presented at the American Headache Society Annual Meeting in Boston suggest that non-invasive medical devices offer effective interventions for indiv…

AHS 2017 Meeting: Prochlorperazine More Effective than Hydromorphone for Acute Migraine

Thursday, June 08, 2017—A new comparative study presented at the American Headache Society Annual Meeting in Boston shows that that, in patients who visit the emergency department for acute migraine …

Teva’s Fremanezumab Reduces Monthly Headache Days in Phase 3 Chronic Migraine Study

Thursday, June 01, 2017—    Results from the Phase 3 HALO study suggest that fremanezumab (Teva Pharmaceuticals) reduces the number of monthly headache days in patients with chronic m…

Migraine Prevalence Higher in Collegiate Athletes, New Study Finds

Friday, May 19, 2017—New findings suggest that collegiate athletes have an increased prevalence of migraines, with female athletes being particularly affected. In a retrospective cross-section sur…

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.

 
  • BRYN MAWR COMMUNICATIONS III, LLC